Welltower (NYSE:WELL – Get Free Report) had its price target hoisted by equities research analysts at Mizuho from $141.00 to $170.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the real estate investment trust’s stock. Mizuho’s price target would indicate a potential upside of 12.42% from the stock’s previous close.
Other analysts also recently issued research reports about the stock. Jefferies Financial Group raised shares of Welltower from a “hold” rating to a “buy” rating and lifted their price target for the company from $132.00 to $147.00 in a research report on Thursday, January 2nd. Bank of America lifted their price target on shares of Welltower from $221.00 to $242.00 and gave the company a “buy” rating in a research report on Tuesday, February 18th. Wedbush raised shares of Welltower from a “neutral” rating to an “outperform” rating and lifted their price target for the company from $145.00 to $167.00 in a research report on Friday, February 14th. Raymond James lifted their price objective on shares of Welltower from $145.00 to $155.00 and gave the stock a “strong-buy” rating in a report on Monday, December 16th. Finally, Wells Fargo & Company lifted their price objective on shares of Welltower from $140.00 to $158.00 and gave the stock an “equal weight” rating in a report on Monday, March 10th. One analyst has rated the stock with a sell rating, two have given a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Welltower has an average rating of “Moderate Buy” and an average price target of $152.42.
View Our Latest Stock Report on WELL
Welltower Stock Performance
Welltower (NYSE:WELL – Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The real estate investment trust reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.73. Welltower had a net margin of 11.91% and a return on equity of 3.15%. As a group, sell-side analysts anticipate that Welltower will post 4.88 EPS for the current year.
Institutional Investors Weigh In On Welltower
A number of institutional investors have recently modified their holdings of WELL. Geller Advisors LLC boosted its position in shares of Welltower by 3.7% during the fourth quarter. Geller Advisors LLC now owns 1,911 shares of the real estate investment trust’s stock valued at $241,000 after buying an additional 69 shares during the last quarter. Mather Group LLC. boosted its position in shares of Welltower by 3.8% during the fourth quarter. Mather Group LLC. now owns 2,053 shares of the real estate investment trust’s stock valued at $259,000 after buying an additional 75 shares during the last quarter. Childress Capital Advisors LLC boosted its position in Welltower by 3.7% in the fourth quarter. Childress Capital Advisors LLC now owns 2,152 shares of the real estate investment trust’s stock worth $271,000 after purchasing an additional 76 shares during the last quarter. Woodmont Investment Counsel LLC boosted its position in Welltower by 3.8% in the fourth quarter. Woodmont Investment Counsel LLC now owns 2,213 shares of the real estate investment trust’s stock worth $279,000 after purchasing an additional 81 shares during the last quarter. Finally, Wealthspire Advisors LLC boosted its position in Welltower by 2.5% in the fourth quarter. Wealthspire Advisors LLC now owns 3,451 shares of the real estate investment trust’s stock worth $435,000 after purchasing an additional 83 shares during the last quarter. 94.80% of the stock is owned by hedge funds and other institutional investors.
Welltower Company Profile
Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.
Further Reading
- Five stocks we like better than Welltower
- Trading Halts Explained
- Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 2 Shorted Stocks Under Fire: Do Bulls or Bears Have It Right?
- Should You Invest in Penny Stocks?
- Is Intuitive Machines a Buy After Athena’s Disappointing Landing?
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.